Bone Loss and Fracture Risk Associated with Cancer Therapy

Bone Loss and Fracture Risk Associated with Cancer Therapy Theresa A. Guise Oncologist 2006; 11: 1121-1131 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (required). Learning Objectives After completing this course, the reader should be able to: Identify cancer therapies associated with bone loss. Explain the unique aspects of cancer therapy-associated bone loss. Screen for and manage bone loss in cancer patients. Describe the safety profile of bisphosphonate drug treatment. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Nov. 16, 2006 Most Recent Review: Nov. 16, 2006* Most Recent Update: Nov. 16, 2006 Date Credit Expires: Nov. 16, 2008 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

• Take this course